A nurse, foster mom and the primary provider for a family of eight, Shelly Sepulveda has devoted her life to taking care of ...
When it comes to frequently diagnosed cancers in women, there are two types that are the most common: cervical and ovarian ...
Eterna Therapeutics, Inc. (ERNA) announced Tuesday positive results from a preclinical study on the company's lead cell therapy ...
High heat shock protein 60 (HSP60) expression in patients with ovarian cancer is associated with larger tumors, advanced ...
By successfully turning the “cold” tumor into “hot” – transforming the tumor microenvironment from having low immune activity to an active immune environment – ERNA-101 may not only lead to improved ...
The fight against cancer often begins with uncovering hidden players, and a recent study reveals one such key player: an ...
Cells is under clinical development by ICamuno Biotherapeutics and currently in Phase I for Ovarian Cancer. According to GlobalData, Phase I drugs for Ovarian Cancer have a 73% phase transition ...
A noninvasive method involving brief, localized pulses of magnetic fields could improve chemotherapy effectiveness and reduce ...